Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_provenance.
- NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_assertion description "[An intronic single nucleotide polymorphism in ABCA1 and the APOE epsilon3 allele are associated with reduced LDLc lowering by statins and identify individuals who may be resistant to maximal LDLc lowering by statins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_provenance.
- NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_assertion evidence source_evidence_literature NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_provenance.
- NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_assertion SIO_000772 20031551 NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_provenance.
- NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_assertion wasDerivedFrom gad-20150221 NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_provenance.
- NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_assertion wasGeneratedBy ECO_0000203 NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_provenance.
- gad-20150221 importedOn "2015-02-21" NP161692.RAx2rj191o5LtIglJhpmZ1gjLjwq_l9vTMgoA-xXtrB10130_provenance.